Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2002
10/17/2002CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002CA2442904A1 Benzamidine derivative
10/16/2002EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002EP1248783A1 Arylsulfonic acid salts of pyrimidine-based antiviral agents
10/16/2002EP1248771A1 Method for preparing hydroxypicolinic acid derivatives
10/16/2002EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide
10/16/2002EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002CN1374947A Synthetic reoutes for the preparation of rhionvirus protease inhibitor and key intermediates
10/16/2002CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/16/2002CN1092656C Kinetic oxidaizoles
10/16/2002CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/16/2002CN1092648C Isoxazole derivatives and their use as herbicides
10/16/2002CN1092639C Benzene-fused heterocyclic derivative and use thereof
10/15/2002USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/15/2002US6465656 Acylating/acetylating arylhydrazine, reacting hydrozonoyl halide/sulfate with amine base to form 1-(3-cyano)phenyl-2-(trifluoroacetyl)hydrazine
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465499 Sulphonylbenzazolones
10/15/2002US6465497 Arylthiazolidinedione derivatives
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465492 Heterocyclic compounds
10/15/2002US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002US6465456 For therapy of bacterial diseases
10/15/2002CA2264685C 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002WO2002079200A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079187A1 Methoxy-1,3,5-triazine derivatives as antiviral agents
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079172A1 Method for preparing monocyclic $i(n)-acyl-aminolactam compounds and combinatorial libraries thereof
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002WO2002066440A8 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
10/10/2002WO2002062764A9 Fused heterocyclic compounds
10/10/2002WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002WO2002044173A3 Herbicidal heterocycles
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147334 Vitronectin Receptor Antagonists
10/10/2002US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442481A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246819A1 A method for the preparation of substituted benzene derivatives
10/09/2002EP1246815A1 Phenylpiperazinyl derivatives
10/09/2002EP1246810A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1000025A4 Substituted naphthopyrans
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002CN1092189C Substd. isoxazolines, process for producing them, agent contg. them and their use as safeners
10/08/2002US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462056 Oxazolidines as 5-HT2A-antagonists
10/08/2002US6462049 Low toxicity and persistent insecticides and fungicides; preventing attachment of aquatic organisms; ecosystem friendly; nonpolluting
10/08/2002US6462043 Method for producing substituted-2-nitroguanidine derivatives
10/08/2002US6462042 Tumor necrosis factor alpha converting enzyme inhibitors; inflammatory diseases, autoimmune diseases, cancer, cardio-vascular diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, neurodegeneration, alzheimer's disease, stroke
10/08/2002US6462039 Fungicidal benzoheterocyclyloxime
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076967A1 Process for making taxane derivatives
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076960A1 Transition metal mediated process
10/03/2002WO2002076959A1 Five-membered heterocyclic alkanoic acid derivative
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076956A1 Arylisoxazoline derivatives, method for production and use thereof as pesticides
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 647